<DOC>
	<DOCNO>NCT01273675</DOCNO>
	<brief_summary>It well understood hypertension , dyslipidemia , diabetes mellitus major risk chronic kidney disease . Current guideline recommend screen kidney estimate glomerular filtration function serum creatinine . But utmost effective method GFR would underestimate . Since good correlation notice serum creatinine chronic kidney disease , urinary microalbumin level well patient risk chronic kidney disease . With adequate early education , antihypertensive agent angiotensin convert enzyme inhibitor ( ACEi ) angiotensin II receptor blocker ( ARB ) , could alleviate renal function deterioration severity proteinuria . As result , high sensitive method urgent need early screening disease follow medication ACEi ARB chronic kidney disease patient . In project , investigator go include patient typy II diabetes mellitus combine hypertension treat antihypertensive agent . Such volunteer treat Candesartan 8-16mg/ day maintain systolic blood pressure &lt; 130 mm/Hg , diastolic blood pressure &lt; 80 mm/ Hg goal . Therefore , project would make effort correlation urinary microalbumin biomarkers change Candesartan treatment- one ARB medication 12 week , exploration new biomarkers may relate renal parenchymal injury .</brief_summary>
	<brief_title>An Investigation Effect Candesartan Early Diabetic Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>1 . Type II Diabetic disease hypertension ( BP : systolic 140160 mm/Hg , diastolic 80100 mm/Hg ) 8 week . 2 . HbA1c &lt; 8.0 % 3 . Cre . &lt; 1.5 g/dL eGFR : 89 30 mL/min/1.73 m2 1 . Pregnancy 2 . During observation , BP : systolic &gt; 160 mm/Hg , diastolic &gt; 100 mm/Hg ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Primary disease</keyword>
</DOC>